Internal Medicine, Infectious Disease · Galveston, TX
NPI
1205198405
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
301 University Blvd
Galveston, TX, 77555
Phone (409) 772-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
256 services
Medicare patients, 2024
111
Average age 67
Drug cost, 2024
$300K
185 prescriptions
Company payments, 2024
$105
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Reynoso was code 99232 (hospital e&m - subsequent), 99 times for 41 patients. In total David Reynoso billed 256 services in 14 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 99 | 41 | $59.32 | $5,873 |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 24 | $90.22 | $4,150 |
| 99222 Hospital E&M - Initial | Facility | 35 | 33 | $96.73 | $3,385 |
| 99214 Office E&M - Established | Facility | 14 | 12 | $70.37 | $985 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $134.59 | $1,750 |
By year: 2022 $29K for 399 services; 2023 $17K for 236 services; 2024 $19K for 256 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Reynoso prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 31 prescriptions and refills. In total David Reynoso wrote 185 Medicare prescriptions that cost $300K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 31 | 31 | Under 11 | $129K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 25 | 25 | Under 11 | $90K |
| Amikacin Sulfate Generic | 19 | 19 | Under 11 | $954 |
| Xerava Eravacycline Di-Hydrochloride | 19 | 19 | Under 11 | $13K |
Brand drugs: 95 claims; generic drugs: 90 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid David Reynoso $105 ($105 in general payments such as food, travel and fees) from 1 company. The largest payer was Melinta Therapeutics, LLC with $105.
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 2 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.